Benefits
Proposed appetite suppression via serotonin
HCA inhibits ATP-citrate lyase, causing acetyl-CoA to accumulate and potentially increase malonyl-CoA, which signals hypothalamic satiety centers. HCA may also raise serotonin availability by slowing its breakdown, which is proposed to mildly suppress appetite, though this pathway remains unproven in humans. Some studies show reduced food intake, but results are inconsistent.
Proposed fat-synthesis inhibition
ATP-citrate lyase (ACLY) catalyzes citrate to acetyl-CoA, the first committed step in making fat from carbohydrates. HCA competitively inhibits ACLY, which in theory reduces that conversion. Laboratory support is reasonable, but the human weight effect is small: a pooled meta-analysis found only about 1.3 kg more weight loss than placebo. It is best understood as a proposed mechanism, not a demonstrated weight-loss benefit.
Glycogen synthesis promotion
By inhibiting ACLY and redirecting acetyl-CoA away from fat synthesis, HCA may promote glycogen synthesis in liver and muscle, improving carbohydrate storage rather than fat storage. Glycogen sparing and endurance are a proposed mechanism from mostly animal and small studies, not a demonstrated human benefit.
Mechanism of action
ATP-citrate lyase competitive inhibition
HCA competitively inhibits ATP-citrate lyase (ACLY) by mimicking the transition state of the enzyme-substrate complex. ACLY normally converts mitochondria-exported citrate to acetyl-CoA and oxaloacetate in the cytosol, the rate-limiting step providing acetyl-CoA for fatty acid synthesis and cholesterol synthesis. HCA inhibition reduces cytosolic acetyl-CoA availability for these anabolic pathways.
Serotonin and appetite signaling modulation
Elevated malonyl-CoA from ACLY inhibition activates hypothalamic AMPK, which may modulate serotonin turnover and appetite signaling. Animal studies show increased brain serotonin with HCA, contributing to appetite suppression and reduced food intake, though human evidence for this specific pathway is weak.
Cortisol reduction and stress eating modulation
HCA has demonstrated cortisol-lowering effects in some clinical studies, which may reduce stress-induced eating. The proposed mechanism involves adrenal steroidogenesis modulation, though this pathway is not well-characterized in humans.
Clinical trials
Systematic review and dose-response meta-analysis of eight randomized controlled trials of Garcinia cambogia in 530 adults, pooling change in body weight and other obesity indices. (Golzarand et al. 2020, Complement Ther Med)
530 adults pooled across eight randomized controlled trials.
Garcinia cambogia produced a statistically significant but small reduction in body weight versus placebo (about 1.34 kg) along with small reductions in BMI, percent fat mass and waist circumference. The authors noted that individual trial results were conflicting, so the effect is modest.